<< Back

Steve Chapman

Director

Steve Chapman has served as the Company’s Chief Executive Officer, and as a director on its board of directors, since January 2019. Previously, Mr. Chapman served as the company’s Chief Operating Officer from August 2017 to January 2019, and Chief Commercial Officer from March 2017 to August 2017. Mr. Chapman began working at Natera, Inc. in December 2010 and held positions including the Vice President of Sales and Vice President, Commercial Operations. Mr. Chapman worked previously at Genzyme Genetics Corp., a biotechnology company, from 2003 to 2010. Mr. Chapman holds a Bachelor of Science in Microbiology, Immunology and Molecular Genetics from University of California, Los Angeles.

Footer disclaimer

Footer disclaimer

© Natera 2019. All Rights Reserved. The tests described on this site were developed by Natera, Inc. a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). The tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests.